Indication
Treatment of high-risk neuroblastoma responsive to prior multiagent, multimodality therapy
Loading your page…
Loading your page…
Neuroblastoma
Marketing Authorisation Holder: Norgine B.V.
INN: eflornithine
AI Drug & Interaction Analysis
Free account required
Ask Osler about Ifinwil: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.